UBS Group

UBS Group’s Contineum Therapeutics CTNM Stock Holding History

UBS Group’s Portfolio CTNM Stock Details CTNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$30.4K	Sell
2025 Q1	$92.8K	Sell
2024 Q4	$365K	Buy
2024 Q3	$50.9K	Buy
2024 Q2	$37.1K	Buy